Local CROs team up for international trials


By Dylan Bushell-Embling
Wednesday, 22 May, 2013

Australian CRO Datapharm is building an international network of local CROs, aimed at challenging the outsourcing model for multinational clinical trials.

The Dai-Sys initiative, spearheaded by Datapharm, involves a collaboration of locally entrenched small to mid-sized CROs banding together to offer services to global biotechnology companies.

Dai-Sys promises to be able to help global companies cut down their R&D budgets and take better advantage of local expertise and contacts.

The initiative has members in around 18 countries spanning Europe, Latin America, Australia and New Zealand. CRO members include Datapharm, Altiora, MTZ Clinical Research, LatAm Clinical Trials, Larix and SynCro.

“We are currently in discussions with a number of companies regarding extending the Dai-Sys membership in Asia, Africa and North America,” Datapharm CEO Dr Helen Allars said. “We also want to hear from other CROs who may be interested in being involved.”

Related News

Cancer drug eliminates bone metastasis in lab models

Researchers have developed a novel treatment that is specific to breast cancer bone metastasis...

TGA rejects Alzheimer's drug due to safety concerns

The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd